Amgen announced that all Repatha (evolocumab) devices are now available at a 60% reduced list price. This includes the pre-filled syringe, the SureClick autoinjector, and the Pushtronex device, an ...
In October, Amgen cut the price of a biweekly dose of its cholesterol drug Repatha by 60 percent. Now, the drugmaker has announced another 60 percent price slash, this time to the cost of a monthly ...
Repatha is a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor. Amgen has announced a price reduction for Repatha (evolocumab), bringing the list price of the therapy to $5,850 per year, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results